Nomura Holdings Inc Sutro Biopharma, Inc. Transaction History

Nomura Holdings Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.33 $126,803 - $231,460	43,426 New	43,426 $127,000
Q2 2022 Aug 15, 2022	SELL	$3.41 - $8.95 $426,689 - $1.12 Million	-125,129 Closed	0 $0
Q1 2022 May 18, 2022	SELL	$7.78 - $15.31 $749,252 - $1.47 Million	-96,305 Reduced 43.49%	125,129 $1.07 Million
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $4,332 - $7,153	-304 Reduced 0.14%	221,434 $3.3 Million
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $3.53 Million - $4.68 Million	209,238 Added 1673.9%	221,738 $4.28 Million
Q4 2020 Feb 16, 2021	SELL	$10.16 - $23.98 $497,840 - $1.18 Million	-49,000 Reduced 79.67%	12,500 $272,000
Q3 2020 Nov 12, 2020	BUY	$7.44 - $13.15 $457,560 - $808,725	61,500 New	61,500 $620,000

138

61.6M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $93.4M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.